IL11 and cancer: Other studies have also shown that IL-11 stimulates inflammation, as well as cancer motility and invasion, through the JAK/STAT3, PI3K/Akt, and Ras/ERK pathways, ultimately resulting in an aggressive phenotype [20–22].